A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure.

In recognition of American Heart Month this February, MyMichigan will dedicate its Monday column to a series of educational articles about heart health. This week features heart failure. The Centers ...

People hospitalized for infections—almost any infections—are at substantially increased risk years later for heart failure, ...

A German medical team has developed and tested a possible treatment for people with severe heart failure that could ...

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating ...

A woman with heart failure was kept alive long enough to receive a heart transplant, in part thanks to newly developed ...

Researchers from the Nagoya University Graduate School of Medicine identified an enzyme, alpha-kinase 2 (ALPK2) that is ...

Sheets of lab-grown muscle are being tested as a radical new treatment for heart attacks and heart failure. Promising results ...

The following is a summary of “Patient Characteristics, Management and Long-term Outcomes of Patients with Cardiogenic Shock ...

TX45 improved both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with preserved Ejection Fraction (“PH-HFpEF”), supporting ...